{"database": "lobbying", "table": "lobbying_activities", "rows": [[2347094, "68e10de1-681e-43b4-a43d-32ebe0808df4", "Q3", "BLUE CROSS BLUE SHIELD OF MICHIGAN", 46676, "BLUE CROSS BLUE SHIELD OF MICHIGAN", 2019, "third_quarter", "PHA", "Opioids (Epidemic, Deterrence, Economic Impact Zones); CREATES Act; Drug Pricing; PBM/Prescription Drug Costs Rx Rebates; Direct-to-Consumer Rx Advertising;Rx Rebates; Biosimilars; Drug approval; Drug patents\n\nH.R.1520 - 116th Congress (2019-2020)\nPurple Book Continuity Act of 2019\nSponsor: Rep. Eshoo, Anna G. [D-CA-18]\n\nH.R.1503 - 116th Congress (2019-2020)\nOrange Book Transparency Act of 2019\nSponsor: Rep. Kelly, Robin L. [D-IL-2] \n\nH.R.1499 - 116th Congress (2019-2020)\nProtecting Consumer Access to Generic Drugs Act of 2019\nSponsor: Rep. Rush, Bobby L. [D-IL-1]\n\nH.R.965 - 116th Congress (2019-2020)\nCREATES Act of 2019\nSponsor: Rep. Cicilline, David N. [D-RI-1]\n\nH.R.3 - 116th Congress (2019-2020)\nLower Drug Costs Now Act of 2019\nSponsor: Rep. Pallone, Frank, Jr. [D-NJ-6] \n\nH.R.275 - 116th Congress (2019-2020)\nMedicare Prescription Drug Price Negotiation Act of 2019\nSponsor: Rep. Welch, Peter [D-VT-At Large]\n\nH.R.448 - 116th Congress (2019-2020)\nMedicare Drug Price Negotiation Act\nSponsor: Rep. Cummings, Elijah E. [D-MD-7]", "HOUSE OF REPRESENTATIVES,SENATE", null, 97200, 0, 0, "2019-10-17T14:11:12.277000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2347094"], "units": {}, "query_ms": 21.057953010313213, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}